MDNC — Medinotec Cashflow Statement
0.000.00%
- $58.67m
- $57.08m
- $5.02m
Annual cashflow statement for Medinotec, fiscal year end - February 29th, USD millions except per share, conversion factor applied.
2022 February 28th | 2023 February 28th | 2024 February 29th | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Net Income/Starting Line | -0.124 | -0.353 | -0.405 |
Depreciation | |||
Deferred Taxes | |||
Non-Cash Items | 0.003 | -0.25 | 0.83 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | -0.036 | 0.082 | -0.597 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Prepaid Expenses | |||
Change in Accrued Expenses | |||
Change in Payable / Accrued Expenses | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | -0.137 | -0.491 | 0.014 |
Other Investing Cash Flow Items | -0.091 | -0.53 | 0.01 |
Acquisition of Business | |||
Sale of Business | |||
Other Investing Cash Flow | |||
Cash from Investing Activities | -0.091 | -0.53 | 0.01 |
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 0.277 | 3.58 | -0.008 |
Foreign Exchange Effects | |||
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 0.051 | 2.7 | -0.019 |